
Understanding the proteins that are targeted by the cosmetic drug Botox (onabotulinumtoxinA) could lead to breakthroughs against type 2 diabetes, according to researchers at Heriot-Watt University in Scotland.
Read more
Understanding the proteins that are targeted by the cosmetic drug Botox (onabotulinumtoxinA) could lead to breakthroughs against type 2 diabetes, according to researchers at Heriot-Watt University in Scotland.
Read more